Mental health has been among the causes that Audacy (formerly Entercom) has championed, especially during the past year. That included the launch of a daily “I’m Listening” message from artists, celebrities, media hosts and mental health specialists. Now Audacy is teaming up with Genomind, a company that connects genetic testing with mental health care.
Genomind will back a multiplatform campaign across 15 stations in eight markets, including Baltimore, Dallas, Houston, Los Angeles, New York, Philadelphia, San Diego and Washington. In each case, local Audacy air personalities will promote Genomind’s DNA testing service. Genomind will be the sponsor the “I’m Listening” daily public service announcements as part of Audacy’s yearlong mental health initiative. In addition, Genomind will also serve as the presenting sponsor of Audacy’s annual “I’m Listening” broadcast, a live national program with an aim is to end the stigma of talking about mental health. It airs in September.
“Our partnership with Audacy scales our work allowing us to bring new mental health solutions to millions of Americans who may be suffering in silence or unsure of how to get started,” said Genomind President Kip Olmstead in the announcement. “Audacy’s leadership in mental health is impressive and we are thrilled to find such a progressive and purpose-driven partner,” he added.
As part of their alliance, Audacy says it will become among the first companies to provide Genomind as an employee benefit. The company says the move will help encourage its workers to put more focus on their mental health and wellness.
“Mental health awareness is a major area of focus for us and a crucial pillar of our companywide social impact platform, and we’re excited to further activate our commitment through this partnership with Genomind,” said Sarah Harris, Vice President of Social Impact at Audacy. “We recognize our significant influence and welcome the opportunity to use our voice, coupled with Genomind’s mental health expertise, innovations and technology, to help improve and save lives and continue our shared mission of ending the stigma of talking about mental health.”
Genomind claims its DNA test results give users a blueprint of their genetic profile and its influence on stress and anxiety, mood, focus and memory, habits and substance use, sleep, social behavior, and eating behavior. The cost of the test runs from $400 to $4,000.